Charlotte Retention in Care Study

Status Completed

Clinical Trial Summary

The objective of the Charlotte Retention in Care study is to assess if clinical decision support systems (CDSS) that produce standardized alerts for measures of retention in care across clinics in the city of Charlotte, North Carolina have the ability to increase retention in care measures within clinics and in surveillance reports.

Clinical Trial Description

Multiple Charlotte HIV Clinic providers are participating. "Primary" HIV provider will be defined as the primary physician or advanced care practitioner following a patient, as recorded in their respective Electronic Health Record (EHR) system and identified through CHORUS, a Clinical Decision Support System (CDSS) developed by Epividian. The CDSS will track patient case status as active or inactive (loss to follow-up, transferred medical care, or deceased). Providers will be informed of the study and sites will be contracted to participate in this collaborative research study. This study was approved by the Advarra Institutional Review Board. ;

Study Design

Related Conditions & MeSH terms

HIV I Infection

Clinical Trial Details

NCT number	NCT03584048
Study type	Observational [Patient Registry]
Source	Epividian
Contact
Status	Completed
Phase
Start date	July 1, 2018
Completion date	October 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04585737` - Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF	Phase 4
Not yet recruiting	`NCT06282783` - Studying Topiramate for Re-Activating the HIV-1 Reservoir	Phase 1/Phase 2
Not yet recruiting	`NCT03622177` - Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection
Recruiting	`NCT05854381` - To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV	Phase 1
Enrolling by invitation	`NCT05071378` - Leveraging Family-Based Assets for Black MSM In House Ball Communities	N/A
Completed	`NCT05421806` - A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real World/
Completed	`NCT04568395` - Acute Effects of TCIG vs ECIG in PLWH	N/A
Recruiting	`NCT04887675` - Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI	N/A
Recruiting	`NCT04820933` - Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV	Early Phase 1
Recruiting	`NCT06005610` - Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy	Phase 2
Recruiting	`NCT05947890` - Evaluating the Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living With and Without HIV in South Africa	Phase 2
Recruiting	`NCT05187429` - Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy	Phase 1/Phase 2
Active, not recruiting	`NCT05601128` - A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA	Phase 3
Completed	`NCT04675255` - Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism	N/A
Recruiting	`NCT05110963` - Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments	N/A
Completed	`NCT03986099` - Community Based Antiretroviral Therapy (CBART) Among Children on Chronic ART	N/A
Completed	`NCT04971343` - Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol
Completed	`NCT04725877` - VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers	Phase 1
Recruiting	`NCT04618198` - Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa	Phase 3
Completed	`NCT05383456` - The Visceral Adiposity Measurement and Observation Study